Multi-Pathway Pigment Correction: Combines Tranexamic Acid, engineered peptides, and exosomes to target melanin synthesis at every stage of pigment production.
Fades Melasma & Resistant Dark Spots: Visibly reduces stubborn sun spots, age spots, and hormonal pigmentation without hydroquinone toxicity or mandatory rest cycles.
Calms Post-Inflammatory Hyperpigmentation (PIH): Suppresses micro-inflammation pathways to prevent dark mark formation following breakouts or clinical procedures.
Exosome & Biosome™ Cellular Delivery: Biomimetic exosomes and nanolipid carriers deliver active proteins and brightening agents directly to target melanocytes.
Gentle, Non-Drying & Non-Irritating: Brightens skin without the peeling, redness, or barrier compromise typical of harsh acid peels.
Optimized for Post-Treatment Recovery: Accelerates tissue repair while preventing rebound post-procedure pigmentation following lasers, microneedling, or peels.
AM and/or PM | Targeted Pigment Step (Step 3: Correct & Brighten)
After cleansing and applying AnteAGE MD® Biosome™ Serum, dispense 1 to 2 pumps of Biosome™ Brightener onto clean fingertips. Smooth evenly over the face, neck, décolleté, or localized dark spots. Allow the treatment to absorb completely before following with your moisturizer, AnteAGE MD® Biosome™ Accelerator, or daily sunscreen.
Recommended Protocol:
Daily Corrective Use: Apply twice daily (morning and evening) for maximum pigment suppression.
System Layering: Apply after AnteAGE MD® Biosome™ Serum and before AnteAGE MD® Biosome™ Accelerator or AnteAGE® Barrier Repair.
Post-Procedure Protocol: Safe to introduce into post-treatment regimens after clinical procedures to protect newly resurfaced skin from post-inflammatory pigment rebound.
AM: Daily application of broad-spectrum SPF 30 or higher (such as Mesoprotech Melan 130 or Mineral Matt Fluid) is strictly required. For clients managing melasma or PIH, broad-spectrum tinted sunscreen containing iron oxides provides critical visible-light protection.
Amare Clinical Tip: Managing hyperpigmentation in melanin-rich skin (Fitzpatrick IV–VI) or melasma-prone clients requires a non-inflammatory approach. Traditional hydroquinone or harsh acid treatments can cause thermal irritation that triggers secondary post-inflammatory hyperpigmentation. AnteAGE MD® Biosome™ Brightener uses Tranexamic Acid and anti-inflammatory Stem Cytokines to clear pigment without inducing thermal stress or barrier breakdown.
Tranexamic Acid: A potent plasmin inhibitor that halts the chemical signaling between keratinocytes and melanocytes, blocking UV- and inflammation-induced pigment production.
Biomimetic Exosomes & Biosomes™: Specialized nano-vesicles derived from stem cell media that facilitate cellular communication, calm micro-inflammation, and drive active ingredients deep into epidermal layers.
Human Bone Marrow Stem Cytokines & Growth Factors: Anti-inflammatory growth factors that repair damaged tissue, support matrix density, and prevent post-inflammatory pigment triggers.
Engineered Brightening Peptides (N-Acetyl Glucosamine & Oligopeptides): Advanced synthetic peptides that inhibit tyrosinase enzyme activity and block melanosome transfer to surface cells.
Niacinamide (Vitamin B3): Calms surface redness, reinforces lipid barrier function, and prevents pigment transfer to epidermal keratinocytes.
Aqua (Water), Human Bone Marrow Stem Cell Conditioned Media, Tranexamic Acid, Niacinamide, Biosome Lipid Complex (Phospholipids, Phytosterols, Ceramides), Acetyl Glucosamine, Oligopeptide-68, Hydrogenated Lecithin, Sodium Oleate, Glycerin, Sodium Hyaluronate, Hydroxyethylcellulose, Polysorbate 20, Disodium EDTA, Phenoxyethanol, Ethylhexylglycerin, Sodium Hydroxide.
